Source: MarketScreener

Amplyx Pharmaceuticals: Arix Bioscience : Amplyx unveils expanded pipeline and reports Phase 2 data from lead programme

(marketscreener.com) Amplyx unveils expanded pipeline and reports Phase 2 data from lead programme 17th September 2019 Positive preliminary Phase 2 safety and efficacy data from lead programme APX001 (fosmanogepix) Phase 2-ready programme for the treatment of BK virus infection...http://www.marketscreener.com/ARIX-BIOSCIENCE-PLC-34067690/news/Arix-Bioscience-Amplyx-unveils-expanded-pipeline-and-reports-Phase-2-data-from-lead-programme-29215400/?utm_medium=RSS&utm_content=20190917

Read full article »

Top Competitors or Alternatives

Missing a competitor? Contribute!

Est. Annual Revenue
Est. Employees
Ciara Kennedy's photo - President & CEO of Amplyx

President & CEO

Ciara Kennedy

CEO Approval Rating

89/100

Amplyx is a biotechnology company that researches, develops and commercializes novel therapeutics for the treatment of fungal infections. Read more